WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) shares fell 0.3% during trading on Thursday . The company traded as low as $23.84 and last traded at $23.84. 424 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 1,239 shares. The stock had previously closed at $23.90.
WisdomTree BioRevolution Fund Price Performance
The firm has a 50-day moving average price of $20.80 and a 200 day moving average price of $18.85. The company has a market cap of $3.58 million, a price-to-earnings ratio of 17.03 and a beta of 1.01.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Jane Street Group LLC grew its holdings in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 16,864 shares of the company’s stock after acquiring an additional 5,306 shares during the quarter. Jane Street Group LLC owned 11.24% of WisdomTree BioRevolution Fund worth $231,000 as of its most recent SEC filing.
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Further Reading
- Five stocks we like better than WisdomTree BioRevolution Fund
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
